Brief: Auris Medical Announces Significant Inhibition Of Tumor Growth With Oligophore Sirna Targeting Nf-Κb In Murine Model Of Adult T-Cell Leukemia / Lymphoma

Altamira Therapeutics

21/06/2021 13:38

June 21 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES SIGNIFICANT INHIBITION OF TUMOR
GROWTH
WITH OLIGOPHORE SIRNA TARGETING NF-ΚB IN MURINE MODEL OF ADULT
T-CELL LEUKEMIA / LYMPHOMA
    * AURIS MEDICAL HOLDING LTD - TREATMENT WITH OLIGOPHORE
SIRNA
STOPS AGGRESSIVE ATLL TUMOR GROWTH TO NEAR ZERO
    * AURIS MEDICAL HOLDING LTD - SIGNIFICANT REDUCTION IN TUMOR
SIZE,
SPLEEN SIZE AND PERIPHERAL BLOOD LYMPHOCYTE COUNTS

Source text for Eikon:  ID:nGNX6nTs6v 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))